Clinical Trial Update: PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01) [Phase 1]

View source ↗

Summary

A Phase 1 PET imaging trial evaluating a radiolabeled anti-HIV-1 envelope monoclonal antibody (VRC01) in individuals with HIV infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VRC01 (radiolabeled anti-HIV-1 envelope monoclonal antibody) (VRC01)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV-1-infection | Phase 1 | Status: RECRUITING